David Duguid
Main Page: David Duguid (Conservative - Banff and Buchan)Department Debates - View all David Duguid's debates with the Home Office
(6 years, 2 months ago)
Commons ChamberFirst, Sativex was looked at for a particular condition. It is right that drugs are looked at the context of the condition that they are intended to help with. The hon. Gentleman makes a good wider point about whether, once the review is complete, we can get on with it, with any changes made quickly. That is exactly what I intend to do.
As chairman of the all-party group on 22q11.2 deletion syndrome, I know many parents of children who have a rare genetic condition that often goes undiagnosed and, when diagnosed, is not always appropriately treated. From that experience, I am sure that Billy’s family welcome today’s statement. I welcome the fact that elements of the statement show that the Government look to the evidence and respond to the public interest, as well as that of the patient at the forefront.
My hon. Friend is right. The process should absolutely be clinically led. We should listen to evidence from clinicians while drawing on international evidence, too. That is exactly what should feed into the outcome of the review.